166 related articles for article (PubMed ID: 17438529)
1. Loss of Arf causes tumor progression of PDGFB-induced oligodendroglioma.
Tchougounova E; Kastemar M; Bråsäter D; Holland EC; Westermark B; Uhrbom L
Oncogene; 2007 Sep; 26(43):6289-96. PubMed ID: 17438529
[TBL] [Abstract][Full Text] [Related]
2. Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesis.
Uhrbom L; Kastemar M; Johansson FK; Westermark B; Holland EC
Cancer Res; 2005 Mar; 65(6):2065-9. PubMed ID: 15781613
[TBL] [Abstract][Full Text] [Related]
3. Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt.
Uhrbom L; Dai C; Celestino JC; Rosenblum MK; Fuller GN; Holland EC
Cancer Res; 2002 Oct; 62(19):5551-8. PubMed ID: 12359767
[TBL] [Abstract][Full Text] [Related]
4. Sox5 can suppress platelet-derived growth factor B-induced glioma development in Ink4a-deficient mice through induction of acute cellular senescence.
Tchougounova E; Jiang Y; Bråsäter D; Lindberg N; Kastemar M; Asplund A; Westermark B; Uhrbom L
Oncogene; 2009 Mar; 28(12):1537-48. PubMed ID: 19219070
[TBL] [Abstract][Full Text] [Related]
5. Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice.
Wang Y; Zhang Z; Kastens E; Lubet RA; You M
Cancer Res; 2003 Aug; 63(15):4389-95. PubMed ID: 12907609
[TBL] [Abstract][Full Text] [Related]
6. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
[TBL] [Abstract][Full Text] [Related]
7. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG
Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676
[TBL] [Abstract][Full Text] [Related]
8. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
[TBL] [Abstract][Full Text] [Related]
9. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.
Dai C; Celestino JC; Okada Y; Louis DN; Fuller GN; Holland EC
Genes Dev; 2001 Aug; 15(15):1913-25. PubMed ID: 11485986
[TBL] [Abstract][Full Text] [Related]
10. Genetic determinants of malignancy in a mouse model for oligodendroglioma.
Weiss WA; Burns MJ; Hackett C; Aldape K; Hill JR; Kuriyama H; Kuriyama N; Milshteyn N; Roberts T; Wendland MF; DePinho R; Israel MA
Cancer Res; 2003 Apr; 63(7):1589-95. PubMed ID: 12670909
[TBL] [Abstract][Full Text] [Related]
11. IGFBP2 is a candidate biomarker for Ink4a-Arf status and a therapeutic target for high-grade gliomas.
Moore LM; Holmes KM; Smith SM; Wu Y; Tchougounova E; Uhrbom L; Sawaya R; Bruner JM; Fuller GN; Zhang W
Proc Natl Acad Sci U S A; 2009 Sep; 106(39):16675-9. PubMed ID: 19805356
[TBL] [Abstract][Full Text] [Related]
12. Different cooperating effect of p21 or p27 deficiency in combination with INK4a/ARF deletion in mice.
Martín-Caballero J; Flores JM; García-Palencia P; Collado M; Serrano M
Oncogene; 2004 Oct; 23(50):8231-7. PubMed ID: 15378017
[TBL] [Abstract][Full Text] [Related]
13. Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesis.
Sharp R; Recio JA; Jhappan C; Otsuka T; Liu S; Yu Y; Liu W; Anver M; Navid F; Helman LJ; DePinho RA; Merlino G
Nat Med; 2002 Nov; 8(11):1276-80. PubMed ID: 12368906
[TBL] [Abstract][Full Text] [Related]
14. Induction of nevi and skin tumors in Ink4a/Arf Xpa knockout mice by neonatal, intermittent, or chronic UVB exposures.
van Schanke A; van Venrooij GM; Jongsma MJ; Banus HA; Mullenders LH; van Kranen HJ; de Gruijl FR
Cancer Res; 2006 Mar; 66(5):2608-15. PubMed ID: 16510579
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic malignancies associated with increased Stat5 and Bcl-x(L) expressions in Ink4a/Arf-deficient mice.
Sung YH; Park J; Choi B; Kim J; Cheong C; Choi YS; Yang EY; Lee M; Han JS; Park SC; Han TH; Kim TJ; Song J; Rhee K; Lee HW
Mech Ageing Dev; 2005; 126(6-7):732-9. PubMed ID: 15888328
[TBL] [Abstract][Full Text] [Related]
16. A strong candidate gene for the Papg1 locus on mouse chromosome 4 affecting lung tumor progression.
Zhang Z; Wang Y; Herzog CR; Liu G; Lee HW; DePinho RA; You M
Oncogene; 2002 Aug; 21(38):5960-6. PubMed ID: 12185599
[TBL] [Abstract][Full Text] [Related]
17. Ink4a/arf deficiency promotes ultraviolet radiation-induced melanomagenesis.
Recio JA; Noonan FP; Takayama H; Anver MR; Duray P; Rush WL; Lindner G; De Fabo EC; DePinho RA; Merlino G
Cancer Res; 2002 Nov; 62(22):6724-30. PubMed ID: 12438273
[TBL] [Abstract][Full Text] [Related]
18. Tobacco smoke-induced lung tumorigenesis in mutant A/J mice with alterations in K-ras, p53, or Ink4a/Arf.
Wang Y; Zhang Z; Lubet R; You M
Oncogene; 2005 Apr; 24(18):3042-9. PubMed ID: 15846305
[TBL] [Abstract][Full Text] [Related]
19. p53-Dependent and -independent functions of the Arf tumor suppressor.
Sherr CJ; Bertwistle D; DEN Besten W; Kuo ML; Sugimoto M; Tago K; Williams RT; Zindy F; Roussel MF
Cold Spring Harb Symp Quant Biol; 2005; 70():129-37. PubMed ID: 16869746
[TBL] [Abstract][Full Text] [Related]
20. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
